US Stock MarketDetailed Quotes
FLGT Fulgent Genetics
- 18.300
- +0.230+1.27%
Close Nov 29 13:00 ET
- 18.000
- -0.300-1.64%
Post 17:01 ET
559.74MMarket Cap-3315P/E (TTM)
18.315High18.050Low98.32KVolume18.110Open18.070Pre Close1.79MTurnover0.48%Turnover RatioLossP/E (Static)30.59MShares30.68052wk High0.49P/B373.75MFloat Cap16.56052wk Low--Dividend TTM20.42MShs Float189.890Historical High--Div YieldTTM1.47%Amplitude2.725Historical Low18.220Avg Price1Lot Size
About Fulgent Genetics Company
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Company Profile
SymbolFLGT
Company NameFulgent Genetics
Listing DateSep 29, 2016
Issue Price9.00
Founded2016
CEOMr. Ming Hsieh
MarketNASDAQ
Employees1184
Fiscal Year Ends12-31
Address4399 Santa Anita Avenue
CityEl Monte
ProvinceCalifornia
CountryUnited States of America
Zip Code91731
Phone1-626-350-0537
Company Executives
- Name
- Position
- Salary
- Ming Hsieh
- Chairman of the Board and Chief Executive Officer
- 5.31M
- Paul Kim
- Chief Financial Officer and Principal Accounting Officer
- 1.78M
- Jian Xie
- President and Chief Operating Officer
- 1.79M
- Hanlin Gao, M.D.
- Chief Scientific Officer
- 1.49M
- Regina E. Groves
- Independent Director
- 625.60K
- Michael Nohaile, PhD
- Independent Director
- 268.50K
- Linda Marsh
- Independent Director
- 270.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data